跳至主要内容
临床试验/NCT03512912
NCT03512912Unknown不适用

Transcutaneous Electrostimulation of the Calf Muscle and Supervised Walking Therapy for Intermittent cLAudication

Heinrich-Heine University, Duesseldorf1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2018年5月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
20
试验地点
1
主要终点
Walking distance

研究概览

简要总结

Prospective mono-centric trial on patients with peripheral arterial disease and intermittent claudication that receive supervised exercise therapy (group 1) vs. supervised exercise therapy + daily transcutaneous electro-stimulation of the calf muscles.

详细描述

The investigators conduct a prospective mono-centric trial on all patient with peripheral arterial disease with intermittent claudication that receive supervised exercise therapy (SET) and additional transcutaneous electric stimulation (TES) of the calf muscle. SET program consists in once weekly walking training for 75 min under supervision of a professional trainer. Patients are encouraged to continue the training modules at home. TES is performed using the mobile "Veinoplus arterial" device (AdRem Technology, France) on a daily base for 60-120 min at home. Patient outcome will be compared to the retrospectively analyzed results of patients, that received the same SET program alone in the past.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • intermittent claudication due to peripheral arterial disease
  • ankle brachial index </=0.9
  • occlusion or stenosis of the superficial femoral artery

排除标准

  • rest pain or peripheral arterial lesions
  • contraindications for supervised walking therapy
  • non-vascular conditions that limit patients´ walking ability
  • patients that have already received supervised walking therapy
  • occlusion of the deep femoral artery
  • occlusion or high-grade stenoses of the iliac arteries
  • stroke in the last 12 months
  • premenopausal women
  • diabetes mellitus, dialysis, sclerodermia and other conditions that impair leg perfusion
  • active cilostazol therapy or alprostadil-infusion in the last 3 months
  • pacemaker, defibrillator systems, life vest
  • visible muscle contraction is not achieved without pain

结局指标

主要结局

Walking distance

时间窗: 6 months

Measurement of the pain-free and absolute walking distance on a standardized constant load treadmill test

次要结局

未报告次要终点

研究者

发起方
Heinrich-Heine University, Duesseldorf
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Philip Düppers

Dr. med.

Heinrich-Heine University, Duesseldorf

研究点 (1)

Loading locations...

相似试验